Tuesday, December 18, 2007

Aspirin Monotherapy Significantly Improves Surrogate Markers

Once again, aspirin amazes. A small study at the University of Zimbabwe finds that simple aspirin mono-therapy is a potent immune modulator for those diagnosed with HIV.

The data presented in this pilot study show that, the administration of aspirin to HIV-1 infected individuals resulted in a significant increase in T lymphocytes numbers, decreases in p24 and in TNF-α. We are persuaded that there is merit in further investigating the mechanisms through which this combination increased the CD4+ cell count and defining whether this agent has any role in the HIV management algorithms.

No comments: